(Q39119286)

9 September 2017

title

Cannabinoids decrease the th17 inflammatory autoimmune phenotype (English)

1 reference

9 September 2017

0 references

0 references

1 reference

Ewa Kozela

1

1 reference

9 September 2017

Ana Juknat

2

1 reference

9 September 2017

Nathali Kaushansky

3

1 reference

9 September 2017

Neta Rimmerman

4

1 reference

9 September 2017

Avraham Ben-Nun

5

1 reference

9 September 2017

Zvi Vogel

6

1 reference

9 September 2017

publication date

28 July 2013

1 reference

Journal of Neuroimmune Pharmacology

9 September 2017

published in

1 reference

9 September 2017

volume

8

1 reference

9 September 2017

issue

5

1 reference

9 September 2017

page(s)

1265-1276

1 reference

Encephalitogenic T cells that stably express both T-bet and ROR gamma t consistently produce IFNgamma but have a spectrum of IL-17 profiles

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

5-HT and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Th17 cytokines and their emerging roles in inflammation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Autoimmune CD4+ T cell memory: lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

The cytokine storm in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Viability and function in lymphocytes cultured from the horse, chicken, and mouse: effects of different leukocyte enrichment techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabinoids as novel anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Inverse agonism and neutral antagonism at cannabinoid CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

A major lipid raft protein raftlin modulates T cell receptor signaling and enhances th17-mediated autoimmune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabinoids and the immune system: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-013-9493-1

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

12 December 2020

Cell contact-mediated signaling of monocytes by stimulated T cells: a major pathway for cytokine induction.

1 reference

12 December 2020

Remembering MOG: autoantibody mediated demyelination in multiple sclerosis?

1 reference

12 December 2020

Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE

1 reference

12 December 2020

Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells

1 reference

12 December 2020

Distribution of cannabinoid receptors in the central and peripheral nervous system.

1 reference

12 December 2020

Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).

1 reference

12 December 2020

Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.

1 reference

12 December 2020

Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

1 reference

12 December 2020

Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis

1 reference

12 December 2020

Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma

1 reference

12 December 2020

IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis

1 reference

12 December 2020

TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

The role of macrophages in THC-induced alteration of the cytokine network.

1 reference

12 December 2020

Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells

1 reference

12 December 2020

Interferon gamma production in blood lymphocytes correlates with disability score in multiple sclerosis patients

1 reference

12 December 2020

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us?

1 reference

12 December 2020

IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.

1 reference

12 December 2020

10.1007/S11481-013-9493-1

Identifiers

DOI

1 reference

9 September 2017

1 reference